Background: The adhesion of Staphylococcus aureus to platelets is a critical first step in endovascular infection. S. aureus is known to form biofilms and detached cells are likely responsible for initiating bloodborne secondary infections. Although several previous studies have evaluated the mechanisms of S. aureus-platelet binding, standard procedures have used suspension-grown cells, which are known to differ in their adhesion properties from biofilm-derived cells.

Methods: This study used both shake flask-grown cells (hereafter, "suspension-grown cells") and cells derived from growing biofilms to compare the level and mechanisms of adhesion to immobilized platelets under physiologically relevant shear conditions. Of specific interest were the roles of clumping factor A (ClfA) and plasma proteins in supporting adhesion.

Results: S. aureus cells collected after 24 h of biofilm growth demonstrate significantly reduced levels of binding to immobilized platelets in the presence of exogenous plasma proteins, in comparison with suspension-grown cells. These adhesion results correlate directly with ClfA expression levels for the different cell populations.

Conclusions: The results presented herein demonstrate that the mode of growth, temporal adhesin expression pattern, and hydrodynamic shear govern S. aureus adhesion to immobilized platelets. ClfA was identified as the critical binding adhesin, regardless of the mode or phase of growth.

Download full-text PDF

Source
http://dx.doi.org/10.1086/596316DOI Listing

Publication Analysis

Top Keywords

immobilized platelets
16
staphylococcus aureus
8
suspension-grown cells
8
adhesion immobilized
8
plasma proteins
8
cells
6
aureus
5
platelets
5
adhesion
5
differential binding
4

Similar Publications

. Adult medulloblastoma (AMB) patients should receive postoperative craniospinal irradiation (CSI) as a standard treatment. Volumetric intensity-modulated arc therapy (VMAT) is a promising method for CSI.

View Article and Find Full Text PDF
Article Synopsis
  • Bioengineered livers are being studied as alternatives to traditional liver transplants, addressing donor shortages, but they face issues like thrombosis due to incomplete endothelial layers.
  • This study focuses on applying heparin to decellularized liver scaffolds to improve blood compatibility, cell adhesion, and new blood vessel formation.
  • Results showed that heparin not only reduced blood clotting and increased cell attachment but also significantly enhanced the growth of blood vessels in the scaffolds when tested in mice.
View Article and Find Full Text PDF

This study aimed to investigate the benefits of using three-dimensional (3D)-printed hip joint fixators after intra-arterial chemotherapy (IAC) by inguinal femoral artery puncture in children with retinoblastoma. Overall, 79 cases of retinoblastoma who had undergone IAC through the femoral artery were selected and divided into an observation group of 50 cases and an intervention group of 29 cases according to the hemostasis method employed. The patients in the observation group were treated with sandbags for hemostasis, while those in the intervention group were given 3D-printed hip joint fixators to help immobilize the hips and sandbags.

View Article and Find Full Text PDF
Article Synopsis
  • Recent developments have improved our understanding of the molecular processes that lead to thrombus formation, particularly regarding deep vein thrombosis (DVT), which can be triggered by various factors like trauma, immobility, or genetic issues.
  • About half of DVT cases are unprovoked, involving mechanisms such as venous stasis and hypoxia, raising the importance of immunothrombosis, especially during conditions like COVID-19 that exacerbate inflammation and promote microthrombi formation.
  • Research involving animal models and clinical studies has revealed the intricate relationship between immune cells, blood components, and various factors influencing coagulation, providing a deeper insight into the causes of hypercoagulability and venous thromboembolism.
View Article and Find Full Text PDF
Article Synopsis
  • Medical devices that contact blood can cause clotting and other complications, which is typically managed using anticoagulants and antiplatelet agents, though these can increase bleeding risks.
  • A new method investigates coating polydimethylsiloxane (PDMS) surfaces with an antithrombin-heparin complex and tissue plasminogen activator to inhibit clotting and dissolve early clots.
  • Different coating processes were tested, and the results showed that a specific sequential application of these agents improved their effectiveness and stability, suggesting potential for better blood compatibility in medical devices.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!